BlackRock’s Vyant Bio, Inc. Common Stock VYNT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-26,558
| Closed | -$15.4K | – | 5687 |
|
|
2023
Q1 | $15.4K | Hold |
26,558
| – | – | ﹤0.01% | 5280 |
|
|
2022
Q4 | $18.7K | Sell |
26,558
-1
| -0% | -$2 | ﹤0.01% | 5387 |
|
|
2022
Q3 | $74K | Hold |
26,559
| – | – | ﹤0.01% | 5267 |
|
|
2022
Q2 | $121K | Sell |
26,559
-15,424
| -37% | -$67.7K | ﹤0.01% | 5186 |
|
|
2022
Q1 | $301K | Sell |
41,983
-750
| -2% | -$4.36K | ﹤0.01% | 5015 |
|
|
2021
Q4 | $288K | Buy |
42,733
+641
| +2% | +$6.56K | ﹤0.01% | 5017 |
|
|
2021
Q3 | $490K | Sell |
42,092
-334
| -0.8% | -$4.62K | ﹤0.01% | 4756 |
|
|
2021
Q2 | $794K | Buy |
42,426
+9,497
| +29% | +$177K | ﹤0.01% | 4579 |
|
|
2021
Q1 | $764K | Buy |
32,929
+25,596
| +349% | +$648K | ﹤0.01% | 4548 |
|
|
2020
Q4 | $102K | Hold |
7,333
| – | – | ﹤0.01% | 4582 |
|
|
2020
Q3 | $152K | Hold |
7,333
| – | – | ﹤0.01% | 4454 |
|
|
2020
Q2 | $111K | Hold |
7,333
| – | – | ﹤0.01% | 4475 |
|
|
2020
Q1 | $101K | Hold |
7,333
| – | – | ﹤0.01% | 4349 |
|
|
2019
Q4 | $219K | Buy |
7,333
+7,282
| +14,278% | +$174K | ﹤0.01% | 4304 |
|
|
2019
Q3 | $1K | Buy |
51
+3
| +6% | +$58 | ﹤0.01% | 4955 |
|
|
2019
Q2 | $1K | Buy |
48
+4
| +9% | +$125 | ﹤0.01% | 4998 |
|
|
2019
Q1 | $2K | Buy |
44
+3
| +7% | +$123 | ﹤0.01% | 4846 |
|
|
2018
Q4 | $1K | Buy |
41
+4
| +11% | +$337 | ﹤0.01% | 4929 |
|
|
2018
Q3 | $6K | Buy |
37
+1
| +3% | +$148 | ﹤0.01% | 4793 |
|
|
2018
Q2 | $5K | Sell |
36
-263
| -88% | -$39.8K | ﹤0.01% | 4836 |
|
|
2018
Q1 | $74K | Sell |
299
-6
| -2% | -$1.69K | ﹤0.01% | 4389 |
|
|
2017
Q4 | $85K | Buy |
305
+33
| +12% | +$12.6K | ﹤0.01% | 4361 |
|
|
2017
Q3 | $110K | Sell |
272
-10
| -4% | -$5.21K | ﹤0.01% | 4352 |
|
|
2017
Q2 | $168K | Buy |
282
+11
| +4% | +$6.43K | ﹤0.01% | 4299 |
|
|
2017
Q1 | $167K | Buy |
+271
| New | +$96.4K | ﹤0.01% | 4252 |
|
|
2014
Q2 | – | Hold |
0
| – | – | – | 3241 |
|
|
2014
Q1 | – | Hold |
0
| – | – | – | 3180 |
|
Other funds holding VYNT
BlackRock's VYNT Position: Q2 2023 in Review
BlackRock sold out of Vyant Bio, Inc. Common Stock (VYNT) in Q2 2023, closing a stake of 26,558 shares — an estimated $15.4K sold.
BlackRock first reported a position in VYNT in Q1 2017 and held it in 25 quarters. The position peaked at $794K in Q2 2021. 1 fund tracked by Wall St. Rank holds VYNT as of Q2 2023.
- BlackRock reported no remaining Vyant Bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
- BlackRock sold 26,558 Vyant Bio, Inc. Common Stock shares in Q2 2023, an estimated $15.4K.
- BlackRock first reported a position in Vyant Bio, Inc. Common Stock in Q1 2017 and held it in 25 quarters.
- BlackRock's Vyant Bio, Inc. Common Stock position peaked at $794K in Q2 2021.
- 1 fund tracked by Wall St. Rank held Vyant Bio, Inc. Common Stock as of Q2 2023.
Based on BlackRock's 13F filing for Q2 2023, filed 11 Aug 2023.